Treatment Guide: Biologics for Psoriasis

Health & Lifestyle
368

Listen to article (english)

Translate to Spanish or other 102 languages!

As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. Image for illustration purposes
As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. Image for illustration purposes

Medical News Today

- Advertisement -

Biologics are injectable medications that pharmaceutical companies make from living cells in a lab or through a biological process. They change or stop specific cytokine activities inside immune cells that cause inflammation in psoriasis. 

As biologics target specific parts of the immune system, they can be safer than broad-spectrum medications that suppress the entire immune system. 

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/biologics-for-psoriasis?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-26&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Advance in the Treatment of Acute Heart Failure Identified
Next article
Driscoll Children’s Hospital Prepares for Grand Opening 

More Articles

New Strategy Helps Immune System Fight High‑Grade Ovarian Cancer

Researchers at the University of California San Diego and collaborators have discovered a new way to help the immune system fight ovarian cancer by changing how tumors communicate with nearby immune cells.

Study Highlights Dangers of Alcohol Use and Risk for Colorectal Cancer

Mega Doctor News CLEVELAND CLINIC - Research continues to show the negative impact...

Researchers Uncover Why Colorectal Tumors Rely on Sugar to Grow

Despite advances in surgery and therapies, patients with metastatic colorectal cancer continue to have poor outcomes, highlighting the need for novel treatments.

Cedars‑Sinai Develops AI Platform to Guide Pancreatic Cancer Treatment Choices

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.
- Advertisement -